logo
Plus   Neg
Share
Email

Dechra Pharma Confirms FY Outlook In Line With Management View

Dechra Pharmaceuticals Plc. (DPH.L) confirmed that the outlook for the full year is in line with management expectations, however the balance of trading will be more second half weighted than is typical for the company.

In its trading update covering the half year reporting period from 1 July to 31 December 2019, the company said group net revenue for the period increased by about 7% at constant exchange rates or about 7% at actual exchange rates.

Total European Pharmaceuticals segment net revenue for the period increased by 13% at CER or 12% at AER, including the acquisitions of Caledonian and Venco.

North American segment net revenue declined by 2% at CER or flat at AER.

The company said it will announce its Interim Results for the period on 24 February 2020.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Gap Inc. partnered with fashion resale platform thredUP to facilitate the exchange of secondhand cloths. The retailer in a blog post said its customers can bring secondhand clothes in exchange for shopping credit that can be redeemed at Gap, Banana Republic, Athleta, or Janie and Jack. Customers who redeem their credits at Gap brands will receive an additional 15 percent payout bonus. Coca-Cola Co. (KO) on Friday reaffirmed its guidance for the full-year 2020 and provided an update on the expected impact from COVID-19 on first quarter 2020 results, ahead of its presentation at the Consumer Analyst Group of New York (CAGNY) Conference. For fiscal 2020, the company continues to project... Deere & Co. (DE) reported that its net income attributable to the company for the first quarter grew to $517 million or $1.63 per share from $498 million or $1.54 per share in the prior-year quarter. Net sales and revenues for the quarter declined 4 percent to $7.63 billion from $7.98 billion in the...
RELATED NEWS
Follow RTT
>